Molecular and immune-mediated resistance to antibody-drug conjugates in breast cancer
Antibody-drug conjugates (ADCs) have progressively advanced the conceptual framework of targeted oncology, evolving from a way to deliver chemotherapy selectively to tumor cells into drugs that also interact with the immune system to support their acti…